Triad Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Triad Wealth Partners's BMY Position: Q2 2026 in Review
Triad Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 31% in Q2 2026, buying an estimated $98.5K and bringing the position to 7,310 shares worth $479K. The position accounts for 0.03% of the portfolio, ranked #321.
Triad Wealth Partners first reported a position in BMY in Q2 2024 and has held it in 5 quarters since. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Triad Wealth Partners held 7,310 shares of Bristol-Myers Squibb worth $479K as of Q2 2026.
- Triad Wealth Partners bought 1,715 Bristol-Myers Squibb shares in Q2 2026, an estimated $98.5K.
- Bristol-Myers Squibb made up 0.03% of Triad Wealth Partners's portfolio in Q2 2026, its #321 holding.
- Triad Wealth Partners first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 5 quarters since.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Triad Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.